Mono Pharmacare IPO GMP Today ( Grey Market Premium )

Mono Pharmacare IPO GMP Today ( Grey Market Premium )

The Mono Pharmacare IPO commenced on August 28, 2023, and concluded on August 30, 2023. The allotment of shares took place on September 4, 2023, and the initiation of refunds began on September 5, 2023. The shares were credited to the demat accounts of investors on September 6, 2023. Finally, the listing of Mono Pharmacare on the stock exchange occurred on September 7, 2023.

The Mono Pharmacare IPO was priced at ₹26 to ₹28 per share, with a lot size of 4000. The total issue size was ₹14.84 crores, comprising a fresh issue of ₹14.84 crores. The IPO was listed on both the NSE SME.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 10% of the shares, the NII (Non-Institutional Investors) quota was reserved for 45% of the shares, and the retail quota was reserved for 45% of the shares.

Mono Pharmacare IPO Basic Details

Company NameMono Pharmacare Limited
Domain of CompanyMarketing and distribution
of pharmaceutical products
Mono Pharmacare IPO GMP Today₹4
Mono Pharmacare IPO Listing Gain14.29%
Mono Pharmacare IPO Open DateAugust 28, 2023
Mono Pharmacare IPO Close DateAugust 30, 2023
Mono Pharmacare IPO Allotment DateSeptember 4, 2023
Mono Pharmacare IPO Listing DateSeptember 7, 2023
Face Value₹10 per share
Price₹26 to ₹28 per share
Lot Size4000 Shares
Issue Size5,300,000 shares of ₹10
(aggregating up to ₹14.84 Cr)
Fresh Issue5,300,000 shares of ₹10
(aggregating up to ₹14.84 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME
Company PromotersPanilam Lakhatariya And
Supal Lakhatariya

Mono Pharmacare IPO GMP Today:

DateGMPListing GainKostakSubject to
6 September 2023₹414.29%
5 September 2023₹310.71%
4 September 2023₹310.71%
3 September 2023₹310.71%
2 September 2023₹310.71%
1 September 2023₹310.71%
31 August 2023₹310.71%
30 August 2023₹00.00%
29 August 2023₹00.00%
28 August 2023₹00.00%
27 August 2023₹00.00%
26 August 2023₹00.00%

Mono Pharmacare IPO Details:

Established in 1994, Mono Pharmacare Limited is involved in the pharmaceutical product marketing and distribution business. The company offers a wide range of products, including healthcare items, antibiotics, cough and cold remedies, antifungal medications, nutraceuticals, pain relievers, antacids, antiemetics, cardiac-diabetic medicines, and cosmocare products.

To expand its product line in specific therapeutic areas, Mono Pharmacare collaborates with contract manufacturers to produce pharmaceutical products sold under its DLS Export brand name. In 2022, the company acquired DLS Export for ₹609 lakhs.

As of February 28, 2023, Mono Pharmacare has partnered with 168 pharmaceutical companies as distributors and stockists. Additionally, the company has served more than 3,036 customers and vendors, consisting of both retail pharmacy stores and wholesalers.

Mono Pharmacare IPO More Details Click Here

Mono Pharmacare IPO FAQs

When is Mono Pharmacare IPO open?

Mono Pharmacare IPO will open on 28 August 2023.

When is Mono Pharmacare IPO Close?

Mono Pharmacare IPO will be closed on 30 August 2023.

What is Mono Pharmacare IPO GMP Today?

The Mono Pharmacare IPO GMP aka Grey Market Premium is ₹4.

What is Mono Pharmacare IPO Kostak Rates Today?

The Mono Pharmacare IPO Kostak Rate is ₹000.

What is Mono Pharmacare IPO Subject to Sauda Price Today?

The Mono Pharmacare IPO subject to sauda rates is ₹000.

Mono Pharmacare IPO Expected Returns?

The Mono Pharmacare expected return is 14.29%.

How much will be the listing gain in Mono Pharmacare IPO?

Mono Pharmacare IPO will get listing gain of 14.29%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *